Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Veterinary Pharmaceuticals Market Grown from 2024 to 2025?

In recent years, the veterinary pharmaceuticals market has seen significant growth. The market is projected to expand from a size of $35.36 billion in 2024 to $37.87 billion in 2025, representing a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the historical period include a rise in pet population, an increase in personal spending on pets, the expanding influence of e-commerce platforms that facilitate online pharmacies, growth in emerging markets, evolving government initiatives, and an increase in disease prevalence.

What Growth Rate Is Anticipated for the Veterinary Pharmaceuticals Market in the Coming Years?

The market for veterinary pharmaceuticals is predicted to undergo significant expansion in the coming years, with an anticipated worth of $50.59 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.5%. This projected surge during the forecast period could be due to various contributors including rising pet ownership, population growth, increased disposable income, urbanization, wider reach of pet insurance, along with enhanced government backing. Prevalent trends within the forecast span are expected to be the emphasis on stem cell therapy for animal treatment, the application of nanotechnology in veterinary medicine to combat antibiotic resistance, creation of chewable tablets, reliance on telemedicine platforms to mitigate COVID-19 impact, development of highly sophisticated vaccines, prioritization of super-combo parasiticides, adoption of subunit and virus-like particle (VLP)-based vaccines, and the quest for strategic alliances and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3809&type=smp

Who Are the Leading Companies in the Veterinary Pharmaceuticals Market?

Major companies operating in the veterinary pharmaceuticals market include Zoetis Inc, Merck & Co., Inc, Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co,.Ltd, Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd, Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Trifecta Pharmaceuticals USA LLC., Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd , UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., Global Vet (U) Ltd

What Are the Key Drivers of the Veterinary Pharmaceuticals Market?

One of the key drivers for the veterinary pharmaceuticals market is the escalating rate of disease prevalence among animals. With the rise in disease incidence in both livestock and pets, there is an increasing necessity for medicaments to treat these animal diseases. For example, the Banfield State of Pet Health Report shows that the incidence of diabetes in dogs has seen an upsurge of around 79.7%, escalating from 13.1 cases per 10,000 to 23.6 cases. Simultaneously, there has been an 18% surge in the disease prevalence among cats. Consequently, the escalating rate of animal diseases is causing an elevation in the demand for the veterinary pharmaceuticals market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3809&type=smp

What Are the Key Market Segments in the Veterinary Pharmaceuticals Industry?

The veterinary pharmaceuticals market covered in this report is segmented –

1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals

2) By Type Of Animal: Livestock, Companion Animals

3) By Type Of Vaccine: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines

4) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administration

5) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores

Subsegments:

1) By Veterinary Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines

2) By Veterinary Antibiotics: Penicillins, Cephalosporins, Tetracyclines, Fluoroquinolones, Macrolides

3) By Veterinary Parasiticides: Endoparasiticides, Ectoparasiticides, Endectocides, Antiprotozoals

4) By Other Veterinary Pharmaceuticals: Anti-inflammatory Drugs, Analgesics, Hormonal Medications, Antifungals

What Are the Latest Trends in the Veterinary Pharmaceuticals Market?

The surge in the usage of generic drugs for pet healthcare is the new tendency in the veterinary pharmaceutical industry. The cost-effectiveness of these drugs allows pet owners to effectively care for their pets. The FDA has validated 22 generic animal drugs for felines and canines, boosting their acceptance among veterinarians. In a poll of 520 veterinarians by Brakke and Trone Brand Energy Inc., nearly 80% affirmed the use of these drugs to help pet owners save on expenses. However, vets will have to examine the relatively low profit margins provided by manufacturers of such drugs compared with the significant margins of brand-name drugs.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

What Are the Key Regional Markets in the Veterinary Pharmaceuticals Industry?

North America was the largest region in the veterinary pharmaceuticals market in 2024. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in the veterinary pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3809

This Report Delivers Insight On:

1. How big is the veterinary pharmaceuticals market, and how is it changing globally?

2. Who are the major companies in the veterinary pharmaceuticals market, and how are they performing?

3. What are the key opportunities and risks in the veterinary pharmaceuticals market right now?

4. Which products or customer segments are growing the most in the veterinary pharmaceuticals market?

5. What factors are helping or slowing down the growth of the veterinary pharmaceuticals market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model